west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "阿托品" 4 results
  • Evidence-Based Management for Acute Organophosphorus Pesticide Poisoning in Emergency ICU

    Objective To formulate an optimal treatment for patients with acute organophosphorus pesticide poisoning through the evidence-based approach. Methods Based on the clinical questions raised from a real-life patient of acute organophosphorus pesticide poisoning (OP poisoning) in Emergency ICU (EICU), we searched ACP journal club (1991-April, 2006), The Cochrane Library (Issue 1, 2006), MEDLINE (1966-May 2006) and Chinese Biological Medical Database(1978-May 2006) for systematic reviews , clinical randomized controlled trials, cohort and case-control studies using the keywords of “organophosphorus compounds, poisoning, insecticides, oximes, cholinesterase reactivators, and intermediate syndrome”. The quality of the included studies was assessed. Results One Cochrane systematic review and one meta-analysis were included. These two studies concluded that there was no clear evidence on the benefits of oximes for acute organophosphorus pesticide poisoning. Based on the current evidence, integrated with clinical expertise and the patients’ values, the oximes were not used for this patient, only low-dose atropine was administered with other supportive therapies. After one week of treatment, the patient was discharged since her vital signs were stable and clinical symptoms were relieved. Conclusions The appropriate management for acute organophosphorus pesticide poisoning has been formulated with the approach of evidence-based medicine. Large-scale, methodologically-sound trials are required.

    Release date:2016-09-07 02:17 Export PDF Favorites Scan
  • Remifentanil Combined with Propofol for Painless Colonoscopy in Patients Awake

    目的 探讨丙泊酚复合瑞芬太尼在患者清醒状态下实施无痛肠镜法的可行性。 方法 2011年7月-2012年7月,将160例行无痛肠镜检查的患者随机分为两组: A组用芬太尼复合丙泊酚麻醉,其中男38例,女42例,平均年龄(48 ± 16)岁,平均体重(53.37 ± 9.5)kg;B组以阿托品0.25~0.5 mg缓慢静脉注射,继而以瑞芬太尼+丙泊酚复合液缓慢静脉滴注,使患者保持清醒状态,其中男43例,女37例,平均年龄(49 ± 15)岁,平均体重(54.26 ± 8.3)kg。观察两组患者检查中血压、心率、呼吸、血氧饱和度变化,检查中体动反应,检查后苏醒时间、定向力恢复、行走时间、离室时间,以及对检查过程的记忆情况。 结果 两组患者均能顺利完成检查,术中记忆率均低,差异无统计学意义(P>0.05)。A组患者循环改变、心动过缓、低氧血症、以及体动反应明显高于B组(P<0.05),B组患者苏醒时间、定向力恢复、行走时间、离室时间,明显短于A组(P<0.05)。 结论  瑞芬太尼-丙泊酚复合液伍用阿托品能够安全应用于患者清醒状态下实施的无痛肠镜检查,具有良好的临床推广价值。

    Release date: Export PDF Favorites Scan
  • 戊已奎醚复合阿托品对小儿围手术期管理影响

    目的 观察术前应用戊已奎醚复合阿托品对患儿静脉复合全身麻醉围手术期管理的影响。 方法2008年3月-2009年2月选择60例患儿,ASAⅠ或Ⅱ级,随机分为3组,A组:静注阿托品;B组:静注戊已奎醚;C组:静注戊已奎醚复合阿托品(阿托品0.25 mg、戊已奎醚0.25 mg),3组均按0.01 mg/kg静注。记录给药前(T0)、进入术间后(T1)、手术开始时(T2)、手术开始30 min(T3)、苏醒期(T4)的HR、MAP、SpO2,记录吸痰次数、吸痰的时间。 结果A组:T1~T4时HR、MAP明显高于T0时(Plt;0.05),与B、C组同时段比较HR明显增快、MAP明显升高(P<0.05);B组:T1、T3、T4时HR低于T0(P<0.05),T2比T0时增高,但比较无差异(P>0.05),T1~T4时MAP与T0时比较无差异(P>0.05);C组:T1、T2时HR略高于T0时,T3、T4时低于T0时,T1~T4时MAP与T0时比较无差异(P>0.05),各时段三组吸痰次数比较无差异(P>0.05)。 结论 戊已奎醚复合阿托品有效地抑制了患儿腺体分泌,使得围手术期心率、血压更加平稳,提高了患儿围手术期的安全。

    Release date:2016-09-08 09:47 Export PDF Favorites Scan
  • tropine Sequential Therapy and Conventional Atropine Treatment of Organophosphorus Pesticide Poisoning in the Efficacy Analysis

    摘要:目的:探讨有机磷农药中毒患者阿托品使用方法,提高抢救成功率。方法: 对2005年6月至2009年6月我院收治的有机磷农药中毒病人281例进行分组,所有患者均使用阿托品疗法,A组为2007年以后132例序贯阿托品疗法患者,B组2007年以前为常规使用静推继之肌注阿托品疗法149例患者,根据有机磷农药对胆碱酯酶复能剂的疗效分为高效组和低效组,并结合病情严重程度共分为重度有机磷农药中毒胆碱酯酶复能剂高效组、重度有机磷农药中毒胆碱酯酶复能剂低效组,轻度有机磷农药中毒胆碱酯酶复能剂高效组、轻度有机磷农药中毒胆碱酯酶复能剂低效组4组,分别从达到阿托品化时间、维持阿托品化效果、反跳和中间综合征发生率、开始撤药平均时间、总住院费用、总住院平均时间、护士劳动强度进行总结和分析。结果: 维持阿托品化疗效A组与B组间有显著差异,P值lt;0.01,开始撤药平均时间、总住院平均时间、总住院费用、护士劳动强度A组与B组间均有差异,P值lt;0.05,发生反跳和中间综合征发生率、达到阿托品化时间在高效组间比较无差异,低效组间比较无差异,高效组与低效组比较有显著差异,P值lt;0.01,主要与中毒药物种类和病情严重程度有关,其次与阿托品治疗方法有关。 结论: 序贯阿托品疗法治疗有机磷农药中毒优于常规使用静推继之肌注阿托品疗法。Abstract: Objective: To discussion of atropine in organophosphorus pesticide poisoning patients with the use of two different methods to improve the success rate. Methods: For June 2005 to June 2009 inour hospital a total of organophosphorus pesticide poisoning 281 cases were divided into A group and B group, All patients were using atropine therapy, 132 cases of sequential therapy in patients with atropine is divided into A group, 149 cases of routine use of intravenous injection and intramuscular injection of atropine group patients were divided into B group, From the following aspects were analyzed and summarized, They are the maintenance of the effect of atropinization, the average time for the beginning of withdrawal, the total hospitalization costs, the total average time for hospitalization and nurses labor intensity. According to the organic phosphorus pesticide on the efficacy of cholinesterase agents are divided into efficient and inefficient groups groups, From the types of poisons, toxic ways, poisoning performance and Complications for stratified, They were divided into 4 groups, severe organophosphorus pesticide poisoning and cholinesterase reactivator can be highly effective group, severe organophosphorus pesticide poisoning and cholinesterase reactivator Lowefficacy group, mild organophosphorus pesticide poisoning and cholinesterase reactivator can be highly effective group, mild organophosphorus pesticide poisoning and cholinesterase reactivator Lowefficacy group, Correlation analysis Antijumping and the incidence of intermediate syndrome and atropinization time.Results:Maintain the efficacy of atropine of A group and B were significantly different between groups, Plt;0.01, the average time began to withdraw drugs, the total average time for hospitalization, total hospital charges, nursing labor intensity of A group and B are differences between the two groups, P<0.05. Rebound occurs and the incidence of intermediate syndrome, to atropinization time high between the two groups showed no difference between the two groups showed no differences between inefficient and efficient group and inefficient group were significantly different, Plt;0.01, mainly related to poisoning by drug type and severity of illness, followed with atropine therapy. Conclusion:Atropine sequential therapy is superior to organophosphorus pesticide poisoning by conventional atropine treatmen.

    Release date:2016-09-08 10:12 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content